Literature DB >> 31698596

MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.

Li-Bing Wang1, Liang Feng1, Jing He1, Bo Liu1, Jian-Guang Sun2.   

Abstract

Objective: To investigate whether miR-125a-5p can inhibit the proliferation and invasion of breast cancer cells and induce apoptosis by targeting GAB2.
Methods: qRT-PCR was used to detect the expression of miR-125a-5p in normal mammary epithelial cells and breast cancer cell lines; The miR-125a-5p overexpression plasmid was transiently transfected into MDA-MB-157 cells, and the proliferation, invasion and apoptosis of breast cancer cells were detected by CCK8 kit, Transwell chamber and flow cytometry, respectively; Gene silencing was used to knock down GAB2 gene in MDA-MB-157 cells, and the changes of proliferation, invasion, apoptosis and apoptosis-related proteins in breast cancer cells were detected by CCK8 kit, Transwell chamber, flow cytometry and western blot, respectively; The direct interaction between miR-125a-5p and GAB2 was detected by dual-luciferase reporter assay. The miR-125a-5p overexpression plasmid was transiently transfected into MDA-MB-157 cells, and the expression levels of GAB2 and apoptosis-related proteins were detected by western blot.
Results: The expression of miR-125a-5p in breast cancer cell lines, MDA-MB-157 cells, MDA-MB-361 cells and MDA-MB-415 cells, was significantly lower than that in normal breast epithelial cells, MCF-10A cells; The proliferation and invasion ability of MDA-MB-157 cells transfected with miR-125a-5p were significantly inhibited, and the apoptosis rate was significantly increased; Since GAB2 knocked down, the proliferation and invasion ability of MDA-MB-157 cells were significantly inhibited, while the apoptosis rate was significantly increased, the Bax protein expression was significantly down-regulated, and the Bcl-2 protein expression was significantly up-regulated; The dual-luciferase reporter assay demonstrated that miR-125a-5p can specifically target GAB2. Transfected with miR-125a-5p, the GAB2 protein expression and Bax protein expression were significantly down-regulated, but the Bcl-2 protein expression was significantly up-regulated.
Conclusion: miR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces their apoptosis by negatively regulating GAB2.

Entities:  

Keywords:  Breast cancer ; GAB2 ; apoptosis ; invasion ; miR-125a-5p ; proliferation

Year:  2019        PMID: 31698596     DOI: 10.3934/mbe.2019347

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  5 in total

1.  Oxymatrine inhibits proliferation and apoptosis of human breast cancer cells through the regulation of miRNA-140-5P.

Authors:  Xu Xiao; Xiaolei Hou; Wenda Shi; Chanchan Hu; Yanan Cui; Jiuli Hu; Zongfang Piao; Xiaoqin Zhu; Qingshan Li; Fan Xu
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Propofol‑induced miR‑125a‑5p inhibits the proliferation and metastasis of ovarian cancer by suppressing LIN28B.

Authors:  Juan Zeng; Yu-Kun Li; Fei-Fei Quan; Xin Zeng; Chang-Ye Chen; Tian Zeng; Juan Zou; Wen-Juan Tong
Journal:  Mol Med Rep       Date:  2020-06-11       Impact factor: 2.952

3.  RPARP-AS1/miR125a-5p Axis Promotes Cell Proliferation, Migration and Invasion in Colon Cancer.

Authors:  Yongjun Ren; Caixia Zhao; Yi He; Xuli Min; Hao Xu; Xiao Hu
Journal:  Onco Targets Ther       Date:  2021-10-12       Impact factor: 4.147

4.  miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.

Authors:  Dongmei Li; Limei Chen; Xiaofang Zhang; Yanhua Wang; Chuansheng Huang; Jianglong Li; Feilong He; Wenxing He
Journal:  Mol Med Rep       Date:  2021-09-22       Impact factor: 2.952

Review 5.  Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.

Authors:  Wanqing Weng; Zhongjing Zhang; Weiguo Huang; Xiangxiang Xu; Boda Wu; Tingbo Ye; Yunfeng Shan; Keqing Shi; Zhuo Lin
Journal:  Cancer Cell Int       Date:  2020-06-11       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.